| Dr Mahesh Mathews, MD | |
|
7301 E 2nd St Ste 311, Scottsdale, AZ 85251-5627 | |
| (480) 707-7672 | |
| (480) 707-7673 |
| Full Name | Dr Mahesh Mathews |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 15 Years |
| Location | 7301 E 2nd St Ste 311, Scottsdale, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356570568 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 46853 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| John C. Lincoln North Mountain Hospital | Phoenix, AZ | Hospital |
| Scottsdale Osborn Medical Center | Scottsdale, AZ | Hospital |
| Vi At Silverstone, A Vi And Plaza Companies Commun | Scottsdale, AZ | Nursing home |
| Entity Name | Cigna Healthcare Of Arizona Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043471873 PECOS PAC ID: 1456263573 Enrollment ID: O20031105000515 |
News Archive
St. Jude Medical, Inc., a global medical device company, today announced CE Mark Approval of the Ellipse implantable cardioverter defibrillator (ICD). Designed with feedback from more than 200 physicians from around the world, the Ellipse ICD provides the benefits of advanced features and power in the industry's smallest high-energy ICD.
A poll of Canadians conducted for the Canadian Medical Association (CMA) shows that most feel the steadily increasing cost of providing universal health care in Canada will handcuff governments' ability to provide services such as education, transportation and pension benefits.
Nearly 1 in 4 patients with advanced cancer, treated at Comprehensive Cancer Care Network centers in the US, are receiving innovative drugs matched to DNA mutations in their tumors.
BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, presented preclinical and promising preliminary phase I clinical results with its AMEP biotherapy at the "Electrochemotherapy 1st International Users' Meeting"(Bologna, Italy, November 19-20, 2010).
Results of a small clinical trial show promise for treating a rare neurodegenerative condition that typically kills those afflicted before they reach age 20.
› Verified 5 days ago
| Entity Name | 4c Medical Group Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558654384 PECOS PAC ID: 2769653641 Enrollment ID: O20110926000641 |
News Archive
St. Jude Medical, Inc., a global medical device company, today announced CE Mark Approval of the Ellipse implantable cardioverter defibrillator (ICD). Designed with feedback from more than 200 physicians from around the world, the Ellipse ICD provides the benefits of advanced features and power in the industry's smallest high-energy ICD.
A poll of Canadians conducted for the Canadian Medical Association (CMA) shows that most feel the steadily increasing cost of providing universal health care in Canada will handcuff governments' ability to provide services such as education, transportation and pension benefits.
Nearly 1 in 4 patients with advanced cancer, treated at Comprehensive Cancer Care Network centers in the US, are receiving innovative drugs matched to DNA mutations in their tumors.
BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, presented preclinical and promising preliminary phase I clinical results with its AMEP biotherapy at the "Electrochemotherapy 1st International Users' Meeting"(Bologna, Italy, November 19-20, 2010).
Results of a small clinical trial show promise for treating a rare neurodegenerative condition that typically kills those afflicted before they reach age 20.
› Verified 5 days ago
| Entity Name | Dm Paull Md Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629348735 PECOS PAC ID: 5799945234 Enrollment ID: O20120321000258 |
News Archive
St. Jude Medical, Inc., a global medical device company, today announced CE Mark Approval of the Ellipse implantable cardioverter defibrillator (ICD). Designed with feedback from more than 200 physicians from around the world, the Ellipse ICD provides the benefits of advanced features and power in the industry's smallest high-energy ICD.
A poll of Canadians conducted for the Canadian Medical Association (CMA) shows that most feel the steadily increasing cost of providing universal health care in Canada will handcuff governments' ability to provide services such as education, transportation and pension benefits.
Nearly 1 in 4 patients with advanced cancer, treated at Comprehensive Cancer Care Network centers in the US, are receiving innovative drugs matched to DNA mutations in their tumors.
BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, presented preclinical and promising preliminary phase I clinical results with its AMEP biotherapy at the "Electrochemotherapy 1st International Users' Meeting"(Bologna, Italy, November 19-20, 2010).
Results of a small clinical trial show promise for treating a rare neurodegenerative condition that typically kills those afflicted before they reach age 20.
› Verified 5 days ago
| Entity Name | Mahesh Mathews Md Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861127201 PECOS PAC ID: 5597133579 Enrollment ID: O20221122003607 |
News Archive
St. Jude Medical, Inc., a global medical device company, today announced CE Mark Approval of the Ellipse implantable cardioverter defibrillator (ICD). Designed with feedback from more than 200 physicians from around the world, the Ellipse ICD provides the benefits of advanced features and power in the industry's smallest high-energy ICD.
A poll of Canadians conducted for the Canadian Medical Association (CMA) shows that most feel the steadily increasing cost of providing universal health care in Canada will handcuff governments' ability to provide services such as education, transportation and pension benefits.
Nearly 1 in 4 patients with advanced cancer, treated at Comprehensive Cancer Care Network centers in the US, are receiving innovative drugs matched to DNA mutations in their tumors.
BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, presented preclinical and promising preliminary phase I clinical results with its AMEP biotherapy at the "Electrochemotherapy 1st International Users' Meeting"(Bologna, Italy, November 19-20, 2010).
Results of a small clinical trial show promise for treating a rare neurodegenerative condition that typically kills those afflicted before they reach age 20.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mahesh Mathews, MD 7301 E 2nd St Ste 311, Scottsdale, AZ 85251-5627 Ph: (480) 707-7672 | Dr Mahesh Mathews, MD 7301 E 2nd St Ste 311, Scottsdale, AZ 85251-5627 Ph: (480) 707-7672 |
News Archive
St. Jude Medical, Inc., a global medical device company, today announced CE Mark Approval of the Ellipse implantable cardioverter defibrillator (ICD). Designed with feedback from more than 200 physicians from around the world, the Ellipse ICD provides the benefits of advanced features and power in the industry's smallest high-energy ICD.
A poll of Canadians conducted for the Canadian Medical Association (CMA) shows that most feel the steadily increasing cost of providing universal health care in Canada will handcuff governments' ability to provide services such as education, transportation and pension benefits.
Nearly 1 in 4 patients with advanced cancer, treated at Comprehensive Cancer Care Network centers in the US, are receiving innovative drugs matched to DNA mutations in their tumors.
BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, presented preclinical and promising preliminary phase I clinical results with its AMEP biotherapy at the "Electrochemotherapy 1st International Users' Meeting"(Bologna, Italy, November 19-20, 2010).
Results of a small clinical trial show promise for treating a rare neurodegenerative condition that typically kills those afflicted before they reach age 20.
› Verified 5 days ago
Dr. Sam Saman Fereidouni, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7699 E Pinnacle Peak Rd, Suite 115, Scottsdale, AZ 85255 Phone: 480-300-4663 Fax: 480-300-4888 | |
Dr. Daniel Andrew Wool, ND Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 20801 N Scottsdale Rd Suite 205, Scottsdale, AZ 85255 Phone: 480-389-3265 | |
Helene Wechsler, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10900 N Scottsdale Rd, Suite 104, Scottsdale, AZ 85254 Phone: 480-990-1564 Fax: 480-990-3298 | |
Natasha Ryan, NMD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 8412 E Shea Blvd, Suite 101, Scottsdale, AZ 85260 Phone: 480-874-1515 Fax: 480-991-8395 | |
Evan Scot Trost Ix, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8328 E. Hartford Dr., Scottsdale, AZ 85255 Phone: 480-214-9720 Fax: 480-214-9722 | |
Katayoun Baniriah, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 4845 E Thunderbird Rd, Scottsdale, AZ 85254 Phone: 480-699-7004 Fax: 480-699-6129 | |
Dr. Ronald Lewis Peters, MD, MPH Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 13951 N Scottsdale Rd, Suite 100, Scottsdale, AZ 85254 Phone: 480-607-7999 Fax: 480-607-7998 |